|
Volumn 19, Issue 17-19, 2001, Pages 2742-2748
|
Plant-based vaccines: Unique advantages
|
Author keywords
Escherichia coli heat labile enterotoxin (LT); Plant vaccines; Transmissible gastroenteritis virus (TGEV)
|
Indexed keywords
ANTIGEN;
BACTERIAL TOXIN;
DRUG VEHICLE;
EDIBLE VACCINE;
ENTEROTOXIN B;
EPITOPE;
ESCHERICHIA COLI ENTEROTOXIN;
LIVE VACCINE;
RECOMBINANT PROTEIN;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANTIGEN EXPRESSION;
CONFERENCE PAPER;
CONTROLLED STUDY;
CORN;
CORONAVIRUS;
DIARRHEA;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG SAFETY;
DRUG STABILITY;
ENVIRONMENTAL TEMPERATURE;
GASTROENTERITIS;
IMMUNE RESPONSE;
MOUSE;
NONHUMAN;
NUCLEOTIDE SEQUENCE;
PLANT SEED;
PRIORITY JOURNAL;
SWINE;
TRANSGENIC PLANT;
VACCINE PRODUCTION;
ANIMALS;
BACTERIAL TOXINS;
BIOTECHNOLOGY;
ENTEROTOXINS;
ESCHERICHIA COLI PROTEINS;
MICE;
MICE, INBRED BALB C;
PLANTS, GENETICALLY MODIFIED;
PLASMIDS;
RHIZOBIUM;
TRANSFORMATION, GENETIC;
TRANSMISSIBLE GASTROENTERITIS VIRUS;
VACCINES, SYNTHETIC;
VIRAL PROTEINS;
ZEA MAYS;
|
EID: 0035925713
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(00)00512-0 Document Type: Conference Paper |
Times cited : (203)
|
References (22)
|